Skip to main content

Table 2 Demographic and baseline characteristics summary

From: Clinical benefit of graduated compression stockings for prevention of venous thromboembolism after total knee arthroplasty: post hoc analysis of a phase 3 clinical study of edoxaban

Demographic and other baseline characteristics

No mechanical prophylaxis

GCS alone

N = 100

N = 101

Edoxaban

Enoxaparin

Edoxaban

Enoxaparin

N = 52

N = 48

N = 53

N = 48

Sex, n (%)

    

 Male

11 (21.2)

9 (18.8)

8 (15.1)

9 (18.8)

 Female

41 (78.8)

39 (81.3)

45 (84.9)

39 (81.3)

Age, (y)

    

 Mean ± SD

70.9 ± 7.9

71.7 ± 7.8

73.5 ± 6.1

73.2 ± 7.0

Weight, (kg)

    

 Mean ± SD

63.2 ± 10.2

64.3 ± 11.9

56.8 ± 10.2

60.3 ± 10.1

CLcr, (mL/min)

    

 Mean ± SD

78.3 ± 24.6

76.2 ± 26.5

71.1 ± 20.1

74.9 ± 20.0

Duration of surgery, (h:min)

    

 Mean ± SD

2:03 ± 0:44

1:59 ± 0:35

1:42 ± 0:26

1:45 ± 0:24

Tourniquet use during surgery, n (%)

50 (96.2)

46 (95.8)

42 (79.2)

38 (79.2)

Method of anesthesia, n (%)

    

 General anesthesia

43 (82.7)

35 (72.9)

24 (45.3)

20 (41.7)

 Epidural anesthesia

8 (15.4)

7 (14.6)

17 (32.1)

14 (29.2)

 Lumbar anesthesia

24 (46.2)

24 (50.0)

38 (71.7)

34 (70.8)

Duration from the end of surgery to the start of anticoagulation, (h:min)

    

 Mean ± SD

20:31 ± 2:39

30:41 ± 3:26

19:43 ± 2:59

27:08 ± 2:30

Duration from surgery to ambulation (days)

    

 Mean ± SD

2.2 ± 0.7

2.4 ± 0.8

3.6 ± 1.4

3.8 ± 2.1

Duration of treatment (days)

    

 Mean ± SD

12.1 ± 1.6

11.6 ± 2.6

12.4 ± 1.6

12.4 ± 1.7

Duration of GCS use (days)

    

 Mean ± SD

-

-

9.5 ± 2.7

9.6 ± 2.7

  1. CL cr creatinine clearance, GCS graduated compression stockings, SD standard deviation